INGALLS & SNYDER LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 104 filers reported holding CARDLYTICS INC in Q1 2023. The put-call ratio across all filers is 2.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$278
+159.8%
16,830
-0.3%
0.01%
+160.0%
Q2 2023$107
+84.5%
16,880
-0.8%
0.01%
+66.7%
Q1 2023$58
-51.7%
17,011
-18.0%
0.00%
-57.1%
Q4 2022$120
-99.9%
20,756
-5.6%
0.01%
-41.7%
Q3 2022$207,000
-60.4%
21,981
-6.2%
0.01%
-55.6%
Q2 2022$523,000
-59.6%
23,437
-0.5%
0.03%
-53.4%
Q1 2022$1,295,000
+165.4%
23,547
+219.0%
0.06%
+163.6%
Q4 2021$488,000
-1.6%
7,382
+25.0%
0.02%
-4.3%
Q3 2021$496,0005,9050.02%
Other shareholders
CARDLYTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders